Ken Liu
Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol‐related cirrhosis patients
Liu, Ken; Yip, Terry C. F.; Masson, Steven; Fateen, Waleed; Schwantes‐An, Tae‐Hwi; McCaughan, Geoffrey W.; Morgan, Timothy R.; Aithal, Guruprasad P.; Seth, Devanshi
Authors
Terry C. F. Yip
Steven Masson
Waleed Fateen
Tae‐Hwi Schwantes‐An
Geoffrey W. McCaughan
Timothy R. Morgan
Professor GURUPRASAD AITHAL Guru.Aithal@nottingham.ac.uk
PROFESSOR OF HEPATOLOGY
Devanshi Seth
Abstract
Background and Aims
The aMAP score was recently devised to predict hepatocellular carcinoma (HCC) development. However, its performance was not tested in alcohol-related cirrhosis (ALC). We aimed to validate the aMAP score in a cohort of ALC patients.
Method
Study participants with ALC from a prior genome-wide association study were included. All participants had a history of high alcohol consumption. Cirrhosis was defined clinically, using fibroscan and/or histology. Patients were followed until the last liver imaging, HCC, liver transplantation (LT) or death with the latter two adjusted as competing risks.
Results
A total of 269 ALC patients were included: male (72.5%), Caucasian (98.9%), median age 56 years, and median Child-Pugh score 7. The median aMAP score was 60: 12.3% low-risk, 35.3% medium-risk and 52.4% high-risk. After a median follow-up of 41 months, 14 patients developed HCC, 27 received LT and 104 died. The aMAP score predicted HCC development (hazard ratio 1.12 per point increase, P < .001) with good separation of cumulative incidence function between risk groups. The area under the time-dependent receiver operating characteristics curve for predicting HCC development was 0.83 at 1 year and 0.82 at 5 years which was similar to ADRESS-HCC and Veterans Affairs Healthcare System scores respectively.
Conclusions
We validated the excellent performance of the aMAP score in ALC and affirm its applicability across wider aetiologies.
Citation
Liu, K., Yip, T. C. F., Masson, S., Fateen, W., Schwantes‐An, T., McCaughan, G. W., Morgan, T. R., Aithal, G. P., & Seth, D. (2022). Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol‐related cirrhosis patients. Liver Cancer International, 3(2), 99-104. https://doi.org/10.1002/lci2.47
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 26, 2022 |
Online Publication Date | Mar 12, 2022 |
Publication Date | 2022-06 |
Deposit Date | Mar 16, 2022 |
Publicly Available Date | Mar 16, 2022 |
Journal | Liver Cancer International |
Print ISSN | 2642-3561 |
Electronic ISSN | 2642-3561 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 3 |
Issue | 2 |
Pages | 99-104 |
DOI | https://doi.org/10.1002/lci2.47 |
Keywords | General Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/7606709 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1002/lci2.47 |
Files
Liver Cancer International - 2022 - Liu - Validation Of The AMAP Score To Predict Hepatocellular Carcinoma Development In A (1)
(515 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Structuring white rice with gellan gum reduces the glycemic response in healthy humans
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search